Anti-calculus Efficacy of a Dentrifice Containing Sodium Pyrophosphate and Potassium Pyrophosphate in Heavy Calculus Formers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine the anti-calculus effect of dentrifice containing 5% sodium pyrophosphate and potassium pyrophosphate in a triple-mask placebo controlled randomized clinical trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical and Radiographic Assessments of Potassium Nitrate in Polycarboxylate Versus Mineral Trioxide Aggregate as Pulpotomy Biomaterials in Immature Mandibular First Permanent Molars

NCT03166748

Pulpotomy of Immature Lower First Molar(Apexegenesis)

UNKNOWN NA

Comparative Evaluation of Calcium Silicate-doped Treated Dentin Matrix and Mineral Trioxide Aggregate as Miniature Pulpotomy Biomaterials in Deep Carious Lesions

NCT07302438

Reversible Pulpitis Deep Carious Lesions

NOT_YET_RECRUITING NA

DPC in Primary Molars.

NCT05222243

Direct Pulp Capping in Primary Teeth

COMPLETED PHASE4

Dose Response of a Tubule Occlusion Agent

NCT01075256

Dentine Hypersensitivity Dental Pain

COMPLETED PHASE4

COMPARISON of MINERAL TRIOXIDE AGGREGATE and CALCIUM HYDROXIDE AS INDIRECT PULP CAPPING AGENTS in PRIMARY MOLARS

NCT06807320

Indirect Pulp Cap

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ANTICALCULUS EFFICACY OF PYROPHOSPHATE IN HEAVY CALCULUS FORMERS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

DENTRIFICE CONTAINING 5% SODIUM AND POTASSIUM PYROPHOSPHATE WAS PRESCRIBED AND SUBJECTS WERE EVALUATED AT 3MONTH AND 6 MONTHS

Group Type ACTIVE_COMPARATOR

DENTRIFICE CONTAINING 5% SODIUM AND POTASSIUM PYROPHOSPHATE

Intervention Type DRUG

DENTRIFICE CONTAINING 5% SODIUM AND POTASSIUM PYROPHOSPHATE WAS ADVISED TWICE DAILY FOR 6 MONTHS

Group 2

PLACEBO DENTRIFICE WITHOUT PYROPHOSPATE WAS PRESCRIBED AND SUBJECTS WERE EVALUATED AT 3MONTH AND 6 MONTHS

Group Type PLACEBO_COMPARATOR

PLACEBO DENTRIFICE WITHOUT PROPHOSPHATE

Intervention Type DRUG

PLACEBO DENTRIFICE WITHOUT PYROPHOSPHATE WAS ADVISED TWICE DAILY FOR 6 MONTHS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DENTRIFICE CONTAINING 5% SODIUM AND POTASSIUM PYROPHOSPHATE

DENTRIFICE CONTAINING 5% SODIUM AND POTASSIUM PYROPHOSPHATE WAS ADVISED TWICE DAILY FOR 6 MONTHS

Intervention Type DRUG

PLACEBO DENTRIFICE WITHOUT PROPHOSPHATE

PLACEBO DENTRIFICE WITHOUT PYROPHOSPHATE WAS ADVISED TWICE DAILY FOR 6 MONTHS

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

XTAR

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age group 15-30 years.
2. Subjects who have not received periodontal therapy within preceding 1year.
3. Heavy calculus formers with simplified calculus index score 1.5-3 .

Exclusion Criteria

1. Age group 15-30 years.
2. Subjects who have not received periodontal therapy within preceding 1year.
3. Heavy calculus formers with simplified calculus index score 1.5-3 .

Minimum Eligible Age

15 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes